126 search results for: chronic inflammation

Spotlight on Type 2 <b>Inflammation</b> in the Upper and Lower Airways
Pulmonology
Spotlight on Type 2 Inflammation in the Upper and Lower Airways
expert video

In this video soundbite from the EAACI 2025 symposium, Dr. Zuzana Diamant explains pathophysiological mechanisms underlying asthma and CRSwNP, and how type 2 inflammatory cytokines drive airway remodelling in patients with severe asthma. Additionally, patients with co-existing asthma and CRSwNP have a higher type 2 inflammatory burden than patients with asthma alone.

View more
Immunological Drivers in CSU: Diverse Pathways to Mast Cell Activation
Dermatology
Immunological Drivers in CSU: Diverse Pathways to Mast Cell Activation
expert video

In this video from EADV 2025, Dr. Hawkes reviews the pathophysioogy of CSU with a focus on the role of type 2 inflammation

View more
World Anosmia Awareness Day
On Demand
World Anosmia Awareness Day

Explore our educational resources about loss of smell and the role of type 2 inflammation in CRSwNP, featuring expert insights from Profs. Wytske Fokkens and Joaquim Mullol.

Expert Interview: Inflammatory Cell Infiltrate and Type 2 <b>Inflammation</b> in PN and CSU
Dermatology
Expert Interview: Inflammatory Cell Infiltrate and Type 2 Inflammation in PN and CSU
expert video

Dr. Metz describes the inflammatory cell infiltrate seen in PN and CSU and how inflammatory cells in the skin contribute to a type 2 inflammatory environment.

View more
ADVENT in Orlando, FL 2025
Congress
7
March
2025
Congress
ADVENT in Orlando, 2025

Type 2 inflammation contributes to many dermatologic diseases, which may lead to potentially life-changing burdens and challenges to patients and caregivers. By uncovering the role of type 2 inflammation in the pathophysiology of AD, PN, CSU, and BP, we can move forward in our understanding of each disease. Join global experts for an educational symposium on March 8th that will uncover the role of type 2 inflammation in the pathophysiology of AD, PN, CSU, and BP and explore questions driving current research in each disease.

Emerging Therapeutics: Addressing the Gaps in CSU Patient Care
Dermatology
Emerging Therapeutics: Addressing the Gaps in CSU Patient Care
expert video

In this video from EADV 2025, Professor Metz shares exciting data from therapies recently approved or in late-stage development for CSU.

View more
Expert Interview: Neuroimmune Interactions in PN and CSU
Dermatology
Expert Interview: Neuroimmune Interactions in PN and CSU
expert video

Dr. Kim describes current understandings of neuroimmune interactions in PN and CSU, including the roles of neurogenic inflammation in each disease.

View more
Broadening the Lens: Clinical and Immunological Insights That Inform CSU Management
Dermatology
Broadening the Lens: Clinical and Immunological Insights That Inform CSU Management
expert video

Professors Metz, Netchiporouk, and Hawkes discuss the clinical features, pathophysiology, and therapeutic landscape of CSU, at EADV 2025.

View more
IRS-ISIAN 2024 | Evolving Perspectives in CRSwNP: From Symptom Control to Disease Remission
On Demand
IRS-ISIAN 2024 | Evolving Perspectives in CRSwNP: From Symptom Control to Disease Remission

Presentation highlights from the ADVENT symposium on disease remission in CRSwNP at the 42nd Congress of the International Society of Inflammation and Allergy of the Nose and 24th Congress of the International Rhinologic Society in Tokyo, Japan.

IRS-ISIAN 2024 | The Importance of Understanding Smell Loss and Congestion in CRSwNP
On Demand
IRS-ISIAN 2024 | The Importance of Understanding Smell Loss and Congestion in CRSwNP

Presentation highlights from the ADVENT symposium on smell loss and nasal congestion in CRSwNP at the 42nd Congress of the International Society of Inflammation and Allergy of the Nose and 24th Congress of the International Rhinologic Society in Tokyo, Japan.